The following excerpt is from the company's SEC filing.
One Newton Executive Park
SUPPLEMENT TO PROXY STATEMENT
FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 3, 2021
Dear Allena Stockholder:
proxy statement supplement, dated May 6, 2021, supplements the definitive proxy statement on Schedule 14A (together with subsequent supplements, the
) of Allena Pharmaceuticals, Inc. (the
) that was filed with the Securities and Exchange Commission on April 22, 2021, relating to the Companys 2021 annual meeting of sto ckholders to be held on June 3, 2021 (the
). Except as specifically supplemented by the information contained in this proxy statement supplement, all information set forth in the Proxy Statement continues to apply and should be considered in voting your shares.
Appointment of Proxy Solicitor
engaged Georgeson LLC (
) to assist us with the solicitation of proxies in connection with the 2021 Annual Meeting. We expect to pay Georgeson a fee of $20,000, plus reimbursement for certain expenses related to its
Louis Brenner, M.D.
President and Chief Executive Officer, Director
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE STOCKHOLDER MEETING TO BE HELD ON JUNE 3, 2021:
This supplement, the Proxy Statement, the Companys official notice of Annual Meeting of Stockholders and the Companys 2020 Annual
Report are available at www.voteproxy.com.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following: